دورية أكاديمية

Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study

التفاصيل البيبلوغرافية
العنوان: Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study
المؤلفون: Kim, Young Saing, Sym, Sun Jin, Baek, Min Young, Park, Inkeun, Hong, Junshik, Ahn, Hee Kyung, Park, Jinny, Cho, Eun Kyung, Lee, Woon Ki, Chung, Min, Kim, Hyung-Sik, Lee, Jae Hoon, Shin, Dong Bok
المصدر: Cancer Chemotherapy and Pharmacology. December 2015 76(6):1267-1272
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:03445704
14320843
DOI:10.1007/s00280-015-2881-x